Revenue: The sum of all revenue fields included for a company's operating activities.
Cardiff Oncology, Inc. (CRDF) had Revenue of $0.68M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.68M |
$-45.45M |
|
-- |
|
$0.68M |
|
$49.33M |
|
$-48.65M |
|
$3.22M |
|
$-45.43M |
|
$-45.43M |
|
$-45.43M |
|
$-45.43M |
|
$-45.43M |
|
$-45.43M |
|
$-48.65M |
|
$-48.84M |
|
47.65M |
|
47.65M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$95.05M |
|
$0.90M |
|
$2.14M |
|
$97.19M |
|
$13.43M |
|
-- |
|
$0.81M |
|
$14.24M |
|
$82.95M |
|
$82.95M |
|
$82.95M |
|
66.52M |
|
| Cash Flow Statement Financials | |
$-37.69M |
|
$13.73M |
|
$53.78M |
|
$21.66M |
|
$51.47M |
|
$29.82M |
|
$4.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-7123.13% |
|
-7123.13% |
|
-7151.54% |
|
-6651.68% |
|
-6655.20% |
|
$-37.77M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.88 |
|
413.10 |
|
-54.77% |
|
-54.77% |
|
-46.74% |
|
-54.77% |
|
$1.25 |
|
$-0.79 |
|
$-0.79 |
|